E-vate helps pharma and biotech teams turn expert, payer and patient insight into clearer strategy, evidence priorities and practical action. We design and moderate structured scientific engagements — including advisory boards, steering committees, insight-to-action workshops, payer discussions, patient/stakeholder programmes and simulation demos — that reveal what conventional discussions often miss: uncertainty, friction, minority views, evidence gaps, resistance and opportunity. Our work supports clinical development, medical affairs, market access, evidence generation, commercial strategy and patient engagement, from early development through to real-world evidence. We are not a traditional MedComms agency. We combine scientific insight, expert moderation and interactive technology to help teams move from discussion to decision with greater confidence.
Looking for a particular E-vate employee's phone or email?
The E-vate annual revenue was $4 million in 2026.
13 people are employed at E-vate.
The NAICS codes for E-vate are [54, 541910, 541, 5419, 54191].
The SIC codes for E-vate are [87, 873].